Registered Trials
-
NCT04527575
Phase 1/2Russia
Total Enrollment: 100
Official Trial Registration:
© 2021 McGill COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.